LONDON, May 10, 2016 /PRNewswire/ --
The medical device contract manufacturing market will witness significant growth during 2016-2021; driven by the rise in number of diseases worldwide.
The global medical device contract manufacturing market was valued at US$ 43,596.0m in 2015, and is expected to reach US$ 77,715.2m, at a CAGR of 10.3% during 2016-2021. The U.S. was the largest market for medical device contract manufacturing, and accounted for 44.2% of the global market. Asian countries, particularly China and India are proving to be attractive low cost destinations for OEMs, witnessing a stronger growth rate compared to other developed countries.
Electronic manufacturing was the largest segment in terms of revenue in the global medical device contract manufacturing market and accounted for 53.6% share in 2015. Rising demand for electronic contract manufacturing devices, low cost, speedy delivery of medical devices and growing healthcare infrastructure in the developing nations would boost market growth in the future. Moreover, it is observed that electronic manufacturing is expanding at a highest CAGR during the forecast period from 2016 to 2021.
This study has been segmented geographically into North America, Europe, Asia, Latin America and the rest of the World.
Each of the following countries have been assessed in greater detail:
- United Kingdom
- Rest of the world
This study investigates commercial trends and revenues of the Medical Device Contract Manufacturing Market Forecast 2016-2021, as well as including historical data from 2012. The report also examines forces driving and restraining revenue expansion at the overall world market, submarket and national levels.
In particular, the data analysis will assist you with:
• Research decisions, presentations, proposals and business plans
• Highlight commercial opportunities - submarkets, products and countries with the highest sales potentials, also giving you multilevel revenue forecasts to 2021
• Benefit your knowledge of the industry, helping your authority and influence
• Provide intelligence on competitors and their activities
• Keep you up to date with commercial developments - events shaping that business
• Help you evaluate companies in clinical provider services
• Explain trends to watch - strengths, weaknesses, opportunities and threats
For access to an executive summary and Table of Content please contact Hugh Andrews.
SOURCE Labrinth Analytics